CD33 and cervical carcinoma: Consistent with the findings obtained in mice, the peripheral blood of the cervical cancer patients with elevated serum G-CSF levels contained significantly higher numbers of MDSC; i.e., CD11b+ CD33+ HLA-DR− cells.